| Filename | Document Type | Assessment Tool | Status | Quality Score | Created Time | Data Source | Actions |
|---|---|---|---|---|---|---|---|
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
68.8%
11/16 passed |
2025-11-22 18:03:17 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-11-22 18:03:17 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-11-22 18:03:17 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-11-22 18:03:17 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-11-22 18:03:17 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-11-22 18:03:17 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
68.8%
11/16 passed |
2025-11-22 18:03:17 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-11-22 18:03:17 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
81.2%
13/16 passed |
2025-11-22 18:03:17 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-11-22 18:03:17 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-11-22 18:03:17 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-11-22 18:03:17 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-11-22 18:03:17 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-11-22 18:03:17 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
68.8%
11/16 passed |
2025-11-22 18:03:17 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-11-22 18:03:17 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
81.2%
13/16 passed |
2025-11-22 18:03:17 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
50.0%
8/16 passed |
2025-11-22 18:03:17 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
25.0%
2/8 passed |
2025-11-22 18:03:17 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
50.0%
8/16 passed |
2025-11-22 18:03:17 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-11-22 18:03:17 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-11-22 18:03:17 | ||
| joc-26-03-190.pdf | Unknown | - | Completed | - | 2025-11-22 18:03:17 | ||
| joc-26-03-190.pdf | Other | - | Completed | - | 2025-11-22 18:03:17 | ||
| Evaluation_of_long-term_benefits_and_cost-effectiveness_ofnation-wide_colorectal_cancer_screening_strategies_in_China_in20202060__a_modelling_analysis.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-11-22 18:03:17 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-11-22 18:03:17 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-11-22 18:03:17 | ||
| Camaione_2013_tham_inh_mo_hinh.pdf | Unknown | - | Completed | - | 2025-11-22 18:03:17 | ||
| systematic_review_vancomycin_model_pediatric.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
31.2%
5/16 passed |
2025-11-22 18:03:17 | ||
| systematic_review_vancomycin_model_pediatric.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| Li-2021-popPK-Vanco-ARC.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-11-22 18:03:17 | ||
| joc-26-03-190.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| test.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
12.5%
1/8 passed |
2025-11-22 18:03:17 | ||
| A_systematic_review_and_meta-analysis_of_integrated_studies_on_antimicrobial_resistance_in_Vietnam_with_a_focus_on_Enterobacteriaceae_from_a_One_Health_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
75.0%
12/16 passed |
2025-11-22 18:03:17 | ||
| archdischild-2023-326124.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
68.8%
11/16 passed |
2025-11-22 18:03:17 | ||
| sustainability-14-01724-v2.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| peltier-et-al-2007-the-interdependence-of-the-factors-influencing-the-perceived-quality-of-the-online-learning.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| sustainability-13-02752.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| sustainability-14-08138-v2.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| Education_for_sustainable_development_in_higher_education_evaluating_coherence_between_theory_and_praxis.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| sustainability-13-03524-v2.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| sustainability-13-12354-v2_1.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| sustainability-13-12354-v2.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| Chapter_4_-_Building_credibility_from_day_zero_-_Short.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| Widding_et_al._-_2009_-_University-affiliated_Venture_Capital_funds_fundi.pdf | Unknown | - | Completed | - | 2025-11-22 18:03:17 | ||
| PRISMA_2020_flow_diagram_new_SRs_v1.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| Cai_2021.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
23.1%
3/13 passed |
2025-11-22 18:03:17 | ||
| Fang_2017_1.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
15.4%
2/13 passed |
2025-11-22 18:03:17 | ||
| Rampello_2019.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
30.8%
4/13 passed |
2025-11-22 18:03:17 | ||
| Rowin_2000.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
15.4%
2/13 passed |
2025-11-22 18:03:17 | ||
| Sartucci_2010.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
7.7%
1/13 passed |
2025-11-22 18:03:17 | ||
| Srotova_2017.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
30.8%
4/13 passed |
2025-11-22 18:03:17 | ||
| Neutrophil_Gelatinase-_Associated_Lipocalin_in_the_Early_Diagnosis_of_Peritonitis-_The_Case_of_Neutrophil_Gelatinase-_Associated_Lipocalin.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
0.0%
0/13 passed |
2025-11-22 18:03:17 | ||
| Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
11.8%
2/17 passed |
2025-11-22 18:03:17 | ||
| Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
11.8%
2/17 passed |
2025-11-22 18:03:17 | ||
| Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-11-22 18:03:17 | ||
| Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-11-22 18:03:17 | ||
| Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-11-22 18:03:17 | ||
| Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-11-22 18:03:17 | ||
| Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-11-22 18:03:17 | ||
| Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
11.8%
2/17 passed |
2025-11-22 18:03:17 | ||
| Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
23.5%
4/17 passed |
2025-11-22 18:03:17 | ||
| Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-11-22 18:03:17 | ||
| Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-11-22 18:03:17 | ||
| BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
17.6%
3/17 passed |
2025-11-22 18:03:17 | ||
| Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
23.5%
4/17 passed |
2025-11-22 18:03:17 | ||
| Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-11-22 18:03:17 | ||
| Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
17.6%
3/17 passed |
2025-11-22 18:03:17 | ||
| Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
11.8%
2/17 passed |
2025-11-22 18:03:17 | ||
| Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-11-22 18:03:17 | ||
| Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
17.6%
3/17 passed |
2025-11-22 18:03:17 | ||
| Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
5.9%
1/17 passed |
2025-11-22 18:03:17 | ||
| Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
11.8%
2/17 passed |
2025-11-22 18:03:17 | ||
| Alvarez_-_2012_-_Effect_of_sprint_interval_training_and_resistance_exercise_on_metabolic_markers_in_overweight_women.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| BadaamZingade_-_2021_-_The_effect_of_traditional_aerobic_exercise_and_sprint_interval_training_on_insulin_resistance_in_men.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Banitalebi_-_2021_-_Sprint_interval_training_vs._combined_aerobic__resistance_training_in_overweight_women_with_type_2.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Cuddy_-_2019_-_Reduced_exertion_high-intensity_interval_training_is_more_effective_at_improving_cardiorespiratory_f.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Freese_-_2015_-_Acute_and_chronic_effects_of_sprint_interval_exercise_on_postprandial_lipemia_in_women_at-risk_for_t.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Gilbertson_-_2019_-_Combining_supervised_run_interval_training_or_moderate-intensity_continuous_training_with_the_diabet.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Honkala_-_2020_-_Exercise_training_improves_adipose_tissue_metabolism_and_vasculature_regardless_of_baseline_glucose.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Jimenez-Maldonado_-_2020_-_Impact_of_high-intensity_interval_training_and_sprint_interval_training_on_peripheral_markers_of_gly.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Motiani_-_2019_-_Effects_of_short-term_sprint_interval_and_moderate-intensity_continuous_training_on_liver_fat_conten.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Ortega_-_2014_-_Higher_insulin-sensitizing_response_after_sprint_interval_compared_to_continuous_exercise.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Petrick_-_2021_-_Endurance_and_sprint_training_improve_glycemia_and_V_O2peak_but_only_frequent_endurance_benefits_blo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Ruffino_-_2017_-_A_comparison_of_the_health_benefits_of_reduced-exertion_high-intensity_interval_training_REHIT_and.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Sjoros_-_2018_-_Increased_insulin-stimulated_glucose_uptake_in_both_leg_and_arm_muscles_after_sprint_interval_and_mo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Skleryk_-_2013_-_Two_weeks_of_reduced-volume_sprint_interval_or_traditional_exercise_training_does_not_improve_metabo.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Sun_-_2019_-_Twelve_weeks_of_low_volume_sprint_interval_training_improves_cardio-metabolic_health_outcomes_in_ove.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| elife-04490-v2.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| Berinstein_1998.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
100.0%
17/17 passed |
2025-11-22 18:03:17 | ||
| Ipek_2021.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
88.2%
15/17 passed |
2025-11-22 18:03:17 | ||
| Saedi_2016.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
94.1%
16/17 passed |
2025-11-22 18:03:17 | ||
| Vural_2023.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
100.0%
17/17 passed |
2025-11-22 18:03:17 | ||
| Vural_2025.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
100.0%
17/17 passed |
2025-11-22 18:03:17 | ||
| JSURGRES-D-25-01704_1.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| NEJMoa1503093.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| World_j_surg_-_2004_-_Wang_-_Molecular_Detection_of_APC_Kras_and_p53_Mutations_in_the_Serum_of_Colorectal_Cancer.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| carroll_2024_oi_231495_1704490532.6214.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| The_impact_of_using_pictorial_aids_in_caregivers__3.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Yin_et_al._-_2021_-_Preventing_Home_Medication_Administration_Errors.pdf | Unknown | - | Completed | - | 2025-11-22 18:03:17 | ||
| j_acap_2010_12_007_--_7ccfa682a71ef7b8dd9a46bb8f21954c_--_Annas_Archive_1.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| EBSCO-FullText-08_26_2025_2.pdf | Unknown | - | Completed | - | 2025-11-22 18:03:17 | ||
| Journal_of_Advanced_Nursing_-_2014_-_He_-_A_randomized_controlled_trial_of_the_effectiveness_of_an_educational_intervention.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| The_impact_of_using_pictorial_aids_in_caregivers__3.pdf | Case-Control Study | Newcastle-Ottawa Scale (NOS) for Case-Control Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| Yin_et_al._-_2021_-_Preventing_Home_Medication_Administration_Errors.pdf | Qualitative Study | - | Completed | - | 2025-11-22 18:03:17 | ||
| s13287-025-04377-4.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| pubmed.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| bhan.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| scrt446.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| AICARE.pdf | Unknown | - | Completed | - | 2025-11-22 18:03:17 | ||
| artikel_1.pdf | Cross-sectional Study | AXIS Tool for Cross-sectional Studies | Completed |
0.0%
0/10 passed |
2025-11-22 18:03:17 | ||
| artikel_2.pdf | Diagnostic Study | QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies) | Completed |
0.0%
0/13 passed |
2025-11-22 18:03:17 | ||
| artikel_3.pdf | Unknown | - | Completed | - | 2025-11-22 18:03:17 | ||
| artikel_1.pdf | Cross-sectional Study | AXIS Tool for Cross-sectional Studies | Completed |
0.0%
0/10 passed |
2025-11-22 18:03:17 | ||
| Kang-2024.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| Kang-2023-Management-of-asymptomatic-to-mild-.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| Kang-2021.pdf | Unknown | - | Completed | - | 2025-11-22 18:03:17 | ||
| 2021.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| 2019.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| 2021.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Liu2018.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Ye2024.pdf | Unknown | - | Completed | - | 2025-11-22 18:03:17 | ||
| Ye2024.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Characterizing-healthcare-resource-utilization-in-two-rare-diseases-Kleefstra-syndrome-and-SLC6A1-epileptic-encephalopathy-using-multimodal-realworld-dataOrphanet-Journal-of-Rare-Diseases.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| 5.jccnc-v9n3p215-en.pdf | Cross-sectional Study | AXIS Tool for Cross-sectional Studies | Completed |
0.0%
0/10 passed |
2025-11-22 18:03:17 | ||
| The-enjoyment-of-life-in-patients-with-Alzheimers-disease-correlations-with-caregivers-perceptions-caregiving-attitudes-and-empowerment-levelsBMC-Nursing.pdf | Cross-sectional Study | AXIS Tool for Cross-sectional Studies | Completed |
0.0%
0/10 passed |
2025-11-22 18:03:17 | ||
| s41598-024-81658-7.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| Hochfeld_2016.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| Calmarza_-_Relationship_between_lipoproteina.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| Cao_-_Lipoproteina_levels_are_associated_with_subclinical_calcific.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| Cassldy_-_Sex-specifi_c_associations_of_lipoproteina_with.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| Chehab_-_Association_of_Lipoproteina_Levels_With_Myocardial_Fibrosis_in.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| Cho_-_Increased_risk_of_coronary_artery_calcification_progression_in_subjects_with.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| Chung_-_Coronary_calcification_is_associated_with_elevated.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| Jang_M_-_Differential_impact_of_lipoproteina.pdf | Cohort Study | Newcastle-Ottawa Scale (NOS) for Cohort Studies | Completed |
0.0%
0/8 passed |
2025-11-22 18:03:17 | ||
| annane2002.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| 000.abusive_-_Copy.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 0.tepper2000.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 1-s2.0-S014829632200056X-main.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 1-s2.0-S097038962300099X-main.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 1-s2.0-S0148296324006453-main.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 1-s2.0-S0261517723000018-main.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 1-s2.0-S1029313223000775-main.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 4.Coping_With_Perceived_Abusive_Supervision_The_Role_of_Paranoia.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 6.Abusive_according_to_whom_Manager_and_subordinate_perceptions_of_abusive_supervision_and_supervisors_performance.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 7.A_cross-cultural_examination_of_subordinates_perceptions_of_and_reactions_to_abusive_supervision.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 16.The_Consequences_of_Incongruent_Abusive_Supervision_Anticipation_of_Social_Exclusion_Shame_and_Turnover_Intentions.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 18.MY_FAMILY_MADE_ME_DO_IT_A_CROSS-DOMAIN_SELF-REGULATORY_PERSPECTIVE_ON_ANTECEDENTS_TO_ABUSIVE_SUPERVISION.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 27.How_to_Cope_with_an_Abusive_Leader_Examinations_of_Subordinates_Affective_Reactions_CWB-O_and_Turnover_Intentions.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 29.Making_nice_or_faking_nice_Exploring_supervisors_two-faced_response_to_their_past_abusive_behavior.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 32.Good_Bad_and_Ugly_Leadership_Patterns_Implications_for_Followers_Work-Related_and_Context-Free_Outcomes.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 37.The_dark_side_of_leadership_a_systematic_literature_review.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 1452-48642402393B.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 3104-9765-1-PB.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| a0030687.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| a0038513.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| Abusive_leadership_and_employee_commitment_nexus_Conservation_of_resources_theory_perspective.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| admsci-12-00054-v2.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| admsci-13-00096.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| admsci-14-00177.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| admsci-14-00340.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| admsci-15-00171.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| amj.2015.0460.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| annurev-orgpsych-041015-062539-_NO_NEED_TO_ADD.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| arshad-et-al-2025-impact-of-abusive-supervision-on-employee-engagement-and-job-burnout-via-organisational.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| bjm-09-2021-0338.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| chan-et-al-2023-the-intuitive-and-counterintuitive-effects-of-supportive-and-abusive-supervision-on-hotel-employees.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| de-clercq-et-al-2021-abusive-supervision-occupational-well-being-and-job-performance-the-critical-role-of-attention.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| document.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| Employee_creativity_deterrence.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 1_Systematic_Review_of_Shift_Work_and_Nurses_Health.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 2_Night_shift_work_and_female_breast_cancer_A_Two-Stage_Dose-Response_Meta-Analysis_for_the_Correct_Risk_Definition.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 10549_2022_Article_6792.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 10549_2022_Article_6792.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 10549_2022_Article_6792.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 10549_2022_Article_6792.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 10549_2022_Article_6792.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 12._peerj-18198.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 9._Zamparini_2024.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| 123.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| j.1540-8183.2011.00666.x.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| j.1540-8183.2011.00666.x.pdf | RCT | Cochrane RoB 2 (Risk of Bias tool for randomized trials) | Completed |
0.0%
0/17 passed |
2025-11-22 18:03:17 | ||
| paper_41.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| paper_41.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| paper_321.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 | ||
| paper_41.pdf | Systematic Review | AMSTAR 2 (A MeaSurement Tool to Assess systematic Reviews) | Completed |
0.0%
0/16 passed |
2025-11-22 18:03:17 |